SB 706504 |
Catalog No.GC11922 |
p38 MAPK inhibitor
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 911110-38-8
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cas No. | 911110-38-8 | SDF | |
Chemical Name | 1-(2-((8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)ethyl)-3-isocyanoguanidine | ||
Canonical SMILES | O=C1C=CC2=C(C3=C(C)C=C(F)C=C3)N=C(NCCNC(N[N+]#[C-])=N)N=C2N1C4=C(C=CC=C4F)F | ||
Formula | C24H19F3N8O | M.Wt | 492.46 |
Solubility | <49.25mg/ml in DMSO | Storage | Desiccate at RT |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Complete Stock Solution Preparation Table
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.0306 mL | 10.1531 mL | 20.3062 mL |
5 mM | 0.4061 mL | 2.0306 mL | 4.0612 mL |
10 mM | 0.2031 mL | 1.0153 mL | 2.0306 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC17129 W 54011
- GC38869 Transdermal Peptide TFA
- GN10453 Ginkgolide B
- GC50146 AEG 40730 dihydrochloride
- GC40631 Leukotriene B4-3-aminopropylamide
- GC18804 Cosyntropin (acetate)
- GC33987 23-Hydroxybetulinic acid (Anemosapogenin)
- GC34282 Sofosbuvir impurity D
- GC33396 DL-Serine
- GC36057 Fluconazole mesylate
- GC17545 Vorapaxar
- GC13338 Spiroxatrine
- GC17676 Nafamostat
- GC45070 trans-Clovamide
- GC12472 Amthamine dihydrobromide
- GC12019 TCS HDAC6 20b
- GC31728 AN3199
리뷰
Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *